How Parkinson Disease Genetics Is Guiding Precision Medicine and Targeted Therapies
A review outlines how three decades of Parkinson disease genetic discoveries are advancing precision medicine, targeted treatments, and genetically stratified ...
Tag: Disease-modifying therapies
Multiple Sclerosis Drugs Slow Disability Most When Started Young, MSBase Study Finds
A large MSBase registry study found disease-modifying therapies for relapsing multiple sclerosis were associated with age-dependent reductions in disability progression, ...
Multicenter Study Tracks Ofatumumab Effectiveness and Infection Risks in Multiple Sclerosis
A multicenter Italian cohort study of 424 adults with relapsing multiple sclerosis found that ofatumumab achieved consistent clinical and radiological ...
Two Decades of Multiple Sclerosis Trends Documented Across Northern Italy
A twenty-year population-based cohort study of ten million adults in Lombardy found that multiple sclerosis prevalence more than doubled between ...
Alzheimer’s Researchers Propose Mitochondrial PINK1 as an “Amyloid Switch” in Disease Pathogenesis
A new commentary proposes that the mitochondrial protein PINK1, a central regulator of mitophagy, could act as a direct amyloid ...
Neurotrophic Peptide Therapy Advances Parkinson’s Treatment
In a pioneering advance that could redefine therapeutic strategies for neurodegenerative disorders, a team of researchers led by Krasnienkov, D., ...
POPULAR NEWS
-
Scientists Examine Neural Mechanisms Cognitive Models and Philosophical Views of Consciousness
-
Half of Adolescents With HIV in Nigerian Hospitals Ready for Adult Care
-
MRI Techniques Yield Divergent Estimates of Brain Barrier Water Exchange Across Ages
-
Tanzanian Hospital Study Evaluates Maternal Willingness to Accept Donor Breast Milk